{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:37:32Z","timestamp":1783766252092,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.pcad.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T11:53:24Z","timestamp":1758455604000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Radionuclide imaging in cardio-oncology: A clinical decision-making tool"],"prefix":"10.1016","volume":"93","author":[{"given":"Teodora","family":"Donisan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sykora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinu V.","family":"Balanescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rodriguez-Porcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2025.09.008_bb0005","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehy453","article-title":"Cardio-oncology services: rationale, organization, and implementation","volume":"40","author":"Lancellotti","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2025.09.008_bb0010","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1136\/heartjnl-2022-321324","article-title":"Burden and prognostic impact of cardiovascular disease in patients with cancer","volume":"109","author":"Raisi-Estabragh","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2025.09.008_bb0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ehjci\/jead168","article-title":"Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring","volume":"24","author":"Mikail","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.09.008_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/2042098614529603","article-title":"Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors","volume":"5","author":"Onitilo","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.pcad.2025.09.008_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.736854","article-title":"Risk factors for anthracycline-induced cardiotoxicity","volume":"8","author":"Qiu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0030","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.pcad.2025.09.008_bb0035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11739-012-0794-9","article-title":"Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer","volume":"7","author":"Russo","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0045","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","article-title":"Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification","volume":"3","author":"Bergom","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0055","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","article-title":"Cardiovascular disease after treatment for Hodgkin\u2019s lymphoma: an analysis of nine collaborative EORTC-LYSA trials","volume":"2","author":"Maraldo","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0060","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11912-023-01414-4","article-title":"Risk factors for immune checkpoint inhibitor-mediated cardiovascular toxicities","volume":"25","author":"Yousif","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.pcad.2025.09.008_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2022.03.010","article-title":"Genetics of cancer therapy-associated cardiotoxicity","volume":"167","author":"Kim","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0070","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0075","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the international cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2025.09.008_bb0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1161\/CIR.0000000000001174","article-title":"Cardiovascular imaging in contemporary cardio-oncology: a scientific statement from the American Heart Association","volume":"148","author":"Addison","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2025.09.008_bb0085","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.2967\/jnumed.122.264868","article-title":"Molecular imaging biomarkers in Cardiooncology: a view on established technologies and future perspectives","volume":"64","author":"Kersting","year":"2023","journal-title":"J Nucl Med"},{"issue":"suppl 1","key":"10.1016\/j.pcad.2025.09.008_bb0090","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.thromres.2021.12.017","article-title":"Cardiovascular toxic effects of antitumor agents: pathogenetic mechanisms","volume":"213","author":"Pantazi","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.pcad.2025.09.008_bb0095","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jacc.2010.05.057","article-title":"Agreement of visual estimation of coronary artery calcium from low-dose CT attenuation correction scans in hybrid PET\/CT and SPECT\/CT with standard Agatston score","volume":"56","author":"Einstein","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MNM.0000000000001503","article-title":"Accurate measurement of coronary artery calcium in cancer patients using the CT component of PET\/CT scans","volume":"43","author":"McConachie","year":"2022","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.pcad.2025.09.008_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcct.2021.09.009","article-title":"Detection of subclinical atherosclerosis from PET-CT in patients with breast cancer","volume":"16","author":"Pope","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.pcad.2025.09.008_bb0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s12350-015-0167-7","article-title":"High-risk coronary artery disease, but normal myocardial perfusion: a matter of concern?","volume":"23","author":"Yokota","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0115","first-page":"805","article-title":"201Tl and 99mTc-MIBI gated SPECT in patients with large perfusion defects and left ventricular dysfunction: comparison with equilibrium radionuclide angiography","volume":"40","author":"Manrique","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0120","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s12350-019-01830-9","article-title":"Equilibrium radionuclide angiography: intra- and inter-observer repeatability and reproducibility in the assessment of cardiac systolic and diastolic function","volume":"28","author":"Sachpekidis","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0125","first-page":"942","article-title":"Right and left ventricular volume and ejection fraction by tomographic gated blood-pool scintigraphy","volume":"38","author":"Chin","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0130","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jacc.2022.08.743","article-title":"Advances in multimodality imaging in cardio-oncology: JACC state-of-the-art review","volume":"80","author":"Baldassarre","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0135","first-page":"1773","article-title":"Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter study","volume":"42","author":"Groch","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12968-017-0348-4","article-title":"Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance","volume":"19","author":"Huang","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pcad.2025.09.008_bb0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41569-020-0347-2","article-title":"Vascular toxic effects of cancer therapies","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0150","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/JCMA.0000000000000590","article-title":"Pre-existing chronic kidney disease and hypertension increased the risk of cardiotoxicity among colorectal cancer patients treated with anticancer drugs","volume":"84","author":"Ho","year":"2021","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.pcad.2025.09.008_bb0160","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2025.09.008_bb0165","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s12350-023-03202-w","article-title":"Early detection of cancer therapy cardiotoxicity by radionuclide angiography: an update","volume":"30","author":"Valzania","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/echo.12331","article-title":"Left ventricular ejection fraction and volumes: it depends on the imaging method","volume":"31","author":"Wood","year":"2014","journal-title":"Echocardiography"},{"key":"10.1016\/j.pcad.2025.09.008_bb0175","first-page":"170","article-title":"Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity","volume":"41","author":"de Geus-Oei","year":"2013","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0180","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9149(86)90284-5","article-title":"Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography","volume":"58","author":"Palmeri","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0185","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12350-020-02277-z","article-title":"Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy","volume":"29","author":"Jones","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0190","doi-asserted-by":"crossref","DOI":"10.7717\/peerj-cs.2230","article-title":"Cardiotoxicity detection tool for breast cancer chemotherapy: a retrospective study","volume":"12","author":"Alenezi","year":"2024","journal-title":"PeerJ Comput Sci"},{"key":"10.1016\/j.pcad.2025.09.008_bb0195","article-title":"The predictive value of changes in 18F-FDG PET\/CT cardiac uptake patterns and metabolic parameters for anthracycline based chemotherapy induced cardiac toxicity in lymphoma patients","volume":"20","author":"Lin","year":"2025","journal-title":"PloS One"},{"key":"10.1016\/j.pcad.2025.09.008_bb0200","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.117.191122","article-title":"Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: a translational (18)F-FDG PET\/CT observation","volume":"58","author":"Bauckneht","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0205","first-page":"53","article-title":"Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis","volume":"10","author":"Tong","year":"2024","journal-title":"Cardiooncology"},{"key":"10.1016\/j.pcad.2025.09.008_bb0210","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1161\/CIR.0000000000001032","article-title":"Future perspectives of cardiovascular biomarker utilization in cancer survivors: a scientific statement from the American Heart Association","volume":"144","author":"Zaha","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2025.09.008_bb0215","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s12350-016-0443-1","article-title":"Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET\/MR imaging","volume":"24","author":"Nensa","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1019284","article-title":"Trigger related outcomes of takotsubo syndrome in a cancer population","volume":"9","author":"Safdar","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0225","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2967\/jnumed.110.082784","article-title":"Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity","volume":"52","author":"de Geus-Oei","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0959-8049(94)00357-B","article-title":"Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy","volume":"31A","author":"Vald\u00e9s Olmos","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pcad.2025.09.008_bb0235","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1002\/clc.20725","article-title":"Positron emission tomography combined with computed tomography as an integral component in evaluation of primary cardiac lymphoma","volume":"33","author":"Lee","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0240","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/eurheartj\/ehm218","article-title":"Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging","volume":"28","author":"Weijs","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2025.09.008_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003594","article-title":"(68)Ga-DOTATOC PET\/CT to detect immune checkpoint inhibitor-related myocarditis","volume":"9","author":"Boughdad","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.pcad.2025.09.008_bb0250","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeab189","article-title":"Immune checkpoint inhibitor-associated cardiotoxicity detected by 68Ga-DOTATATE PET\/CT and 68Ga-FAPI PET\/CT","volume":"23","author":"Niu","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.09.008_bb0255","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s12350-020-02307-w","article-title":"Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury\/remodeling","volume":"28","author":"Siebermair","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0260","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.010628","article-title":"Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease","volume":"13","author":"Heckmann","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.09.008_bb0265","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s44161-023-00335-6","article-title":"CCR2 imaging in human ST-segment elevation myocardial infarction","volume":"2","author":"Lavine","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.pcad.2025.09.008_bb0270","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2023.08.016","article-title":"Flurpiridaz F-18 PET myocardial perfusion imaging in patients with suspected coronary artery disease","volume":"82","author":"Maddahi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0275","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00259-022-05991-7","article-title":"Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)","volume":"50","author":"Totzeck","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.09.008_bb0280","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcmg.2018.11.036","article-title":"Coronary microvascular dysfunction: clinical considerations and noninvasive diagnosis","volume":"13","author":"Schindler","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.09.008_bb0285","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jcmg.2022.11.015","article-title":"Second-line myocardial perfusion imaging to detect obstructive stenosis: head-to-head comparison of CMR and PET","volume":"16","author":"Rasmussen","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.09.008_bb0290","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2967\/jnmt.120.246405","article-title":"SNMMI procedure standard\/EANM guideline for gated equilibrium radionuclide angiography","volume":"48","author":"Farrell","year":"2020","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051244","article-title":"The role of vasospasm and microcirculatory dysfunction in fluoropyrimidine-induced ischemic heart disease","volume":"11","author":"Fabin","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0300","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s12350-017-1135-1","article-title":"SPECT myocardial ischemia in the absence of obstructive CAD: contribution of the invasive assessment of microvascular dysfunction","volume":"25","author":"Dja\u00efleb","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0305","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.amjcard.2013.07.031","article-title":"Cardiovascular complications of radiotherapy","volume":"112","author":"Lee","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0310","article-title":"Radiation-induced vascular disease-a state-of-the-art review","volume":"8","author":"Yang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0315","first-page":"E202","volume":"87","author":"Iliescu","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2025.09.008_bb0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.31083\/j.rcm2307227","article-title":"Mechanisms of myocardial ischemia in Cancer patients: a state-of-the-art review of obstructive versus non-obstructive causes","volume":"23","author":"Balanescu","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.887705","article-title":"Radiotherapy-induced cardiotoxicity: the role of multimodality cardiovascular imaging","volume":"9","author":"Podlesnikar","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0330","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2967\/jnumed.123.266046","article-title":"Impact of (68)Ga-FAPI PET\/CT on staging and oncologic Management in a Cohort of 226 patients with various cancers","volume":"64","author":"Koerber","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/jcecho.jcecho_18_22","article-title":"Imaging of cardiac masses: an updated overview","volume":"32","author":"Parato","year":"2022","journal-title":"J Cardiovasc Echogr"},{"key":"10.1016\/j.pcad.2025.09.008_bb0340","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-025-07289-w","article-title":"[(18)F]FDG PET imaging in the differentiation of cardiac masses: an updated systematic review and dual Meta-analysis of diagnostic performance and parameter variability","author":"Rizzo","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.09.008_bb0345","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s12350-021-02790-9","article-title":"Multimodality imaging to distinguish between benign and malignant cardiac masses","volume":"29","author":"Aghayev","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0350","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s12350-019-02022-1","article-title":"Assessment of cardiac tumors by (18)F-FDG PET\/CT imaging: histological correlation and clinical outcomes","volume":"28","author":"Meng","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0355","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2967\/jnumed.111.095364","article-title":"Differentiation of malignant and benign cardiac tumors using 18F-FDG PET\/CT","volume":"53","author":"Rahbar","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0360","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.jcmg.2020.03.021","article-title":"Diagnostic accuracy of cardiac computed tomography and 18-F fluorodeoxyglucose positron emission tomography in cardiac masses","volume":"13","author":"D\u2019Angelo","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.09.008_bb0365","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s12350-020-02510-9","article-title":"Role of (18)F-FDG PET\/CT imaging in cardiac and pericardial masses","volume":"29","author":"Yin","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.09.008_bb0370","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2967\/jnumed.124.267948","article-title":"Cardiac neuroendocrine tumor metastases on (68)Ga-DOTATATE PET\/CT: identification and prognostic significance","volume":"65","author":"Lee","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2024.100692","article-title":"Hybrid PET-MR imaging to assess acute cardiovascular changes in response to thoracic radiotherapy and chemotherapy in cancer patients","volume":"26","author":"Ntentas","year":"2024","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pcad.2025.09.008_bb0380","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.semnuclmed.2024.05.007","article-title":"Cardiac PET\/MRI: recent developments and future aspects","volume":"54","author":"Kazimierczyk","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.pcad.2025.09.008_bb0385","article-title":"Artificial intelligence and imaging: opportunities in cardio-oncology","volume":"15","author":"Madan","year":"2022","journal-title":"Am Heart J Plus"},{"issue":"suppl 1","key":"10.1016\/j.pcad.2025.09.008_bb0390","article-title":"Applications, challenges and future directions of artificial intelligence in cardio-oncology","volume":"55","author":"Ravera","year":"2025","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pcad.2025.09.008_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14062095","article-title":"Artificial intelligence in nuclear cardiac imaging: novel advances, emerging techniques, and recent clinical trials","volume":"14","author":"Golub","year":"2025","journal-title":"J Clin Med"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T05:07:52Z","timestamp":1765775272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062025001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":79,"alternative-id":["S0033062025001422"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2025.09.008","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radionuclide imaging in cardio-oncology: A clinical decision-making tool","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}